BioNTech SE (0A3M) Ownership - Who Owns BioNTech SE?
6 Followers
BioNTech SE (0A3M) Ownership Overview
- 15.80% Insiders
- 6.61% Mutual Funds
- 1.84% Other Institutional Investors
- 1.28% ETFs
- 74.48% Public Companies and Individual Investors
The ownership structure of BioNTech SE (GB:0A3M) stock is a mix of institutional, retail, and individual investors. Approximately 9.72% of the company’s stock is owned by Institutional Investors, 15.80% is owned by Insiders, and 74.48% is owned by Public Companies and Individual Investors.
The ownership structure of BioNTech SE (GB:0A3M) stock is a mix of institutional, retail, and individual investors. Approximately 9.72% of the company’s stock is owned by Institutional Investors, 15.80% is owned by Insiders, and 74.48% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
| Date | Name | Activity | Value |
|---|---|---|---|
| Apr 22, 2026 | Sierk Poetting | $5,527,500 | |
| Feb 12, 2026 | Ugur Sahin | $93,870,900 | |
| Nov 30, 2025 | Ozlem Tureci | $12,666,094 | |
| Nov 13, 2025 | Ugur Sahin | $124,448,321 |
Recent Hedge Fund Trading Activity
| Date | Firm | Activity | Value |
|---|---|---|---|
| Dec 31, 2025 | Bridgewater Associates, Lp | $469,050 | |
| Dec 31, 2025 | Gilder Gagnon Howe & Co Llc. | $3,073,722 | |
| Dec 31, 2025 | Dodge & Cox | $344,099,543 | |
| Dec 31, 2025 | Primecap Management Co | $361,761,047 |
Top Shareholders
| Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| Ugur Sahin | 39,281,320 | Insider | 15.64% | 3,431,616,115 |
| Fidelity Contrafund | 3,982,739 | Institution | 1.59% | 347,932,079 |
| Theofanis Kolokotrones | 3,772,031 | Institution | 1.50% | 329,524,628 |
| John A. Gunn | 3,677,591 | Institution | 1.46% | 321,274,350 |
| Dodge & Cox Funds | 3,043,491 | Institution | 1.21% | 265,879,374 |
| Vanguard Horizon Funds | 2,189,120 | Institution | 0.87% | 191,241,523 |
| BlackRock, Inc. | 1,854,966 | Institution | 0.74% | 162,049,830 |
| Primecap Odyssey Funds | 1,251,756 | Institution | 0.50% | 109,353,404 |
| Ishares | 1,109,228 | Institution | 0.44% | 96,902,158 |
| First Trust | 1,025,140 | Institution | 0.41% | 89,556,230 |
Top Mutual Fund Holders
| Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| Fidelity Contrafund | 3,982,739 | Institution | 1.59% | 347,932,079 |
| Dodge & Cox Funds | 3,043,491 | Institution | 1.21% | 265,879,374 |
| Vanguard Horizon Funds | 2,189,120 | Institution | 0.87% | 191,241,523 |
| Primecap Odyssey Funds | 1,251,756 | Institution | 0.50% | 109,353,404 |
| T. Rowe Price Mid-cap Growth Fund, Inc. | 1,018,613 | Institution | 0.41% | 88,986,032 |
| Europacific Growth Fund | 741,308 | Institution | 0.30% | 64,760,667 |
| Fidelity Investment Trust | 660,800 | Institution | 0.26% | 57,727,488 |
| Mfs Series Trust Xi | 487,157 | Institution | 0.19% | 42,558,036 |
| Fidelity Select Portfolios | 487,053 | Institution | 0.19% | 42,548,950 |
| Fidelity Rutland Square Trust Ii | 360,000 | Institution | 0.14% | 31,449,600 |
FAQ
Who Owns BioNTech SE (GB:0A3M)?
According to the latest TipRanks data, approximately 9.72% of the company's stock is held by institutional investors, 15.80% is held by insiders, and 74.48% is held by public companies and individual investors.
What percentage of BioNTech SE (GB:0A3M) stock is held by institutional investors?
According to the latest TipRanks data, approximately 9.72% of BioNTech SE (GB:0A3M) stock is held by institutional investors: 6.61% by mutual funds, 1.28% by ETFs and 1.84% by other institutional investors.
What percentage of BioNTech SE (GB:0A3M) stock is held by retail investors?
According to the latest TipRanks data, approximately 74.48% of BioNTech SE (GB:0A3M) stock is held by public companies and individual investors.
Who owns the most shares of BioNTech SE (GB:0A3M)?
Ugur Sahin owns the most shares of BioNTech SE (GB:0A3M).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.
